| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.999 | 0 | 1 | Vasodilator | 1 0 DBMET01480 0.995 0 DBMET01481 | DBMET01480 | |
| 0.952 | 0 | 0.992 | Nitric oxide donor | 0.071 0.032 DBMET01480 0.992 0 DBMET01481 | DBMET01481 | |
| 0.696 | 0.014 | 0.749 | Analgesic | 0.749 0.009 DBMET01481 | DBMET01481 | |
| 0.623 | 0.01 | 0.623 | Immunosuppressant | |||
| 0.497 | 0.027 | 0.587 | GABA C receptor rho-3 antagonist | 0.587 0.009 DBMET01480 0.587 0.009 DBMET01481 | DBMET01481 | |
| 0.481 | 0.011 | 0.481 | Peroxidase inhibitor | 0.441 0.015 DBMET01480 0.441 0.015 DBMET01481 | ||
| 0.472 | 0.006 | 0.583 | Alpha-N-acetylglucosaminidase inhibitor | 0.583 0.004 DBMET01480 0.583 0.004 DBMET01481 | DBMET01481 | |
| 0.426 | 0.006 | 0.426 | Tyrosine 3 hydroxylase inhibitor | 0.404 0.008 DBMET01480 0.404 0.008 DBMET01481 | ||
| 0.453 | 0.081 | 0.481 | Caspase 9 stimulant | 0.481 0.068 DBMET01480 0.481 0.068 DBMET01481 | DBMET01481 | |
| 0.365 | 0.006 | 0.466 | GABA C receptor agonist | 0.466 0.004 DBMET01480 0.466 0.004 DBMET01481 | DBMET01481 | |
| 0.431 | 0.075 | 0.512 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.512 0.029 DBMET01480 0.512 0.029 DBMET01481 | DBMET01481 | |
| 0.454 | 0.108 | 0.634 | Antiinflammatory | 0.634 0.045 DBMET01481 | DBMET01481 | |
| 0.345 | 0.008 | 0.345 | UDP-glucose 4-epimerase inhibitor | 0.342 0.008 DBMET01480 0.342 0.008 DBMET01481 | ||
| 0.365 | 0.041 | 0.483 | Calcium channel activator | 0.396 0.026 DBMET01480 0.483 0.006 DBMET01481 | DBMET01481 | |
| 0.328 | 0.004 | 0.328 | Triose-phosphate isomerase inhibitor | 0.301 0.005 DBMET01480 0.301 0.005 DBMET01481 | ||
| 0.359 | 0.051 | 0.512 | Vasodilator, coronary | 0.512 0.014 DBMET01480 0.434 0.026 DBMET01481 | DBMET01480 | |
| 0.364 | 0.094 | 0.364 | Antibacterial | |||
| 0.279 | 0.009 | 0.356 | Ferrochelatase inhibitor | 0.356 0.004 DBMET01480 0.356 0.004 DBMET01481 | DBMET01481 | |
| 0.277 | 0.009 | 0.277 | Death-associated protein kinase 2 inhibitor | |||
| 0.307 | 0.041 | 0.4 | 5 Hydroxytryptamine uptake stimulant | 0.4 0.014 DBMET01480 0.4 0.014 DBMET01481 | DBMET01481 | |
| 0.283 | 0.029 | 0.284 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.284 0.029 DBMET01480 0.284 0.029 DBMET01481 | DBMET01481 | |
| 0.315 | 0.065 | 0.508 | 5 Hydroxytryptamine release stimulant | 0.508 0.026 DBMET01480 0.508 0.026 DBMET01481 | DBMET01481 | |
| 0.311 | 0.063 | 0.507 | Aldehyde oxidase inhibitor | 0.507 0.032 DBMET01480 0.507 0.032 DBMET01481 | DBMET01481 | |
| 0.264 | 0.018 | 0.31 | Succinate dehydrogenase inhibitor | 0.31 0.009 DBMET01480 0.31 0.009 DBMET01481 | DBMET01481 | |
| 0.355 | 0.111 | 0.453 | 5 Hydroxytryptamine release inhibitor | 0.453 0.05 DBMET01480 0.453 0.05 DBMET01481 | DBMET01481 | |
| 0.293 | 0.063 | 0.293 | Insulysin inhibitor | 0.279 0.073 DBMET01480 0.279 0.073 DBMET01481 | ||
| 0.234 | 0.008 | 0.234 | GABA C receptor antagonist | 0.232 0.008 DBMET01480 0.232 0.008 DBMET01481 | ||
| 0.254 | 0.03 | 0.303 | Nitric-oxide synthase stimulant | 0.303 0.011 DBMET01480 0.303 0.011 DBMET01481 | DBMET01481 | |
| 0.224 | 0.006 | 0.224 | Histone deacetylase 2 inhibitor | |||
| 0.269 | 0.064 | 0.391 | Superoxide dismutase inhibitor | 0.391 0.028 DBMET01480 0.391 0.028 DBMET01481 | DBMET01481 | |
| 0.217 | 0.013 | 0.279 | Adenylate kinase inhibitor | 0.279 0.008 DBMET01480 0.279 0.008 DBMET01481 | DBMET01481 | |
| 0.205 | 0.005 | 0.205 | Histone deacetylase class II inhibitor | |||
| 0.211 | 0.014 | 0.289 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.289 0.007 DBMET01480 0.289 0.007 DBMET01481 | DBMET01481 | |
| 0.2 | 0.005 | 0.2 | Histone deacetylase 5 inhibitor | |||
| 0.199 | 0.005 | 0.199 | Histone deacetylase class IIb inhibitor | |||
| 0.198 | 0.005 | 0.198 | Histone deacetylase 6 inhibitor | |||
| 0.254 | 0.064 | 0.394 | DNA synthesis inhibitor | 0.298 0.044 DBMET01480 0.394 0.022 DBMET01481 | DBMET01481 | |
| 0.195 | 0.006 | 0.195 | Histone deacetylase 1 inhibitor | |||
| 0.22 | 0.036 | 0.268 | 5 Hydroxytryptamine 3E antagonist | 0.268 0.01 DBMET01480 0.268 0.01 DBMET01481 | DBMET01481 | |
| 0.195 | 0.013 | 0.281 | Porphobilinogen synthase inhibitor | 0.281 0.006 DBMET01480 0.281 0.006 DBMET01481 | DBMET01481 | |
| 0.184 | 0.007 | 0.332 | Alcohol oxidase inhibitor | 0.332 0.004 DBMET01480 0.332 0.004 DBMET01481 | DBMET01481 | |
| 0.197 | 0.022 | 0.197 | Aminopeptidase B inhibitor | 0.183 0.026 DBMET01480 0.183 0.026 DBMET01481 | ||
| 0.182 | 0.008 | 0.182 | Glutamate decarboxylase inhibitor | 0.167 0.01 DBMET01480 0.167 0.01 DBMET01481 | ||
| 0.173 | 0.01 | 0.187 | Ca2+-transporting ATPase inhibitor | 0.187 0.005 DBMET01480 0.187 0.005 DBMET01481 | DBMET01481 | |
| 0.226 | 0.068 | 0.29 | RNA-directed DNA polymerase inhibitor | 0.29 0.034 DBMET01480 0.29 0.034 DBMET01481 | DBMET01481 | |
| 0.163 | 0.005 | 0.163 | Histone deacetylase class IIa inhibitor | |||
| 0.172 | 0.014 | 0.213 | Phosphofructokinase-1 inhibitor | 0.213 0.01 DBMET01480 0.213 0.01 DBMET01481 | DBMET01481 | |
| 0.191 | 0.034 | 0.248 | GABA C receptor rho-2 antagonist | 0.248 0.012 DBMET01480 0.248 0.012 DBMET01481 | DBMET01481 | |
| 0.195 | 0.038 | 0.214 | Arachidonic acid antagonist | 0.214 0.021 DBMET01480 0.214 0.021 DBMET01481 | DBMET01481 | |
| 0.169 | 0.014 | 0.222 | NADH dehydrogenase inhibitor | 0.222 0.009 DBMET01480 0.222 0.009 DBMET01481 | DBMET01481 | |
| 0.17 | 0.017 | 0.217 | Creatine kinase inhibitor | 0.217 0.008 DBMET01480 0.217 0.008 DBMET01481 | DBMET01481 | |
| 0.188 | 0.038 | 0.221 | Mannose-6-phosphate isomerase inhibitor | 0.221 0.021 DBMET01480 0.221 0.021 DBMET01481 | DBMET01481 | |
| 0.157 | 0.009 | 0.211 | Biliverdin reductase inhibitor | 0.211 0.005 DBMET01480 0.211 0.005 DBMET01481 | DBMET01481 | |
| 0.173 | 0.032 | 0.185 | Adenylate cyclase stimulant | 0.185 0.022 DBMET01480 0.185 0.022 DBMET01481 | DBMET01481 | |
| 0.151 | 0.012 | 0.151 | Phenylalanine 4-hydroxylase inhibitor | 0.132 0.015 DBMET01480 0.132 0.015 DBMET01481 | ||
| 0.156 | 0.019 | 0.185 | DOPA decarboxylase inhibitor | 0.185 0.009 DBMET01480 0.185 0.009 DBMET01481 | DBMET01481 | |
| 0.23 | 0.094 | 0.281 | Interleukin agonist | 0.281 0.058 DBMET01480 0.281 0.058 DBMET01481 | DBMET01481 | |
| 0.136 | 0.001 | 0.136 | Corticosteroid-like | 0.02 0.017 DBMET01481 | ||
| 0.154 | 0.02 | 0.202 | GABA C receptor rho-1 antagonist | 0.202 0.008 DBMET01480 0.202 0.008 DBMET01481 | DBMET01481 | |
| 0.145 | 0.012 | 0.184 | Carbamoyl phosphate synthetase inhibitor | 0.184 0.008 DBMET01480 0.184 0.008 DBMET01481 | DBMET01481 | |
| 0.232 | 0.102 | 0.267 | Gastrin inhibitor | 0.267 0.06 DBMET01480 0.267 0.06 DBMET01481 | DBMET01481 | |
| 0.183 | 0.058 | 0.188 | Phospholipase C inhibitor | 0.188 0.053 DBMET01480 0.188 0.053 DBMET01481 | DBMET01481 | |
| 0.149 | 0.029 | 0.149 | Carbonic anhydrase III inhibitor | 0.136 0.034 DBMET01480 0.136 0.034 DBMET01481 | ||
| 0.138 | 0.018 | 0.181 | Glutamate dehydrogenase inhibitor | 0.181 0.012 DBMET01480 0.181 0.012 DBMET01481 | DBMET01481 | |
| 0.13 | 0.011 | 0.13 | Aminopeptidase microsomal inhibitor | |||
| 0.168 | 0.049 | 0.171 | Cell wall synthesis inhibitor | 0.171 0.046 DBMET01480 0.171 0.046 DBMET01481 | DBMET01481 | |
| 0.152 | 0.037 | 0.152 | 5-Lipoxygenase inhibitor | |||
| 0.124 | 0.012 | 0.172 | Acyl-CoA dehydrogenase inhibitor | 0.172 0.007 DBMET01480 0.172 0.007 DBMET01481 | DBMET01481 | |
| 0.112 | 0.004 | 0.112 | Glucose-6-phosphate isomerase inhibitor | 0.105 0.004 DBMET01480 0.105 0.004 DBMET01481 | ||
| 0.112 | 0.005 | 0.112 | Collagenase inhibitor | |||
| 0.137 | 0.03 | 0.137 | Sphingomyelinase inhibitor | 0.117 0.044 DBMET01480 0.117 0.044 DBMET01481 | ||
| 0.114 | 0.01 | 0.114 | Aminopeptidase N inhibitor | |||
| 0.118 | 0.015 | 0.167 | Argininosuccinate synthase inhibitor | 0.167 0.01 DBMET01480 0.167 0.01 DBMET01481 | DBMET01481 | |
| 0.236 | 0.136 | 0.504 | Cholesterol antagonist | 0.328 0.075 DBMET01480 0.504 0.032 DBMET01481 | DBMET01481 | |
| 0.108 | 0.009 | 0.11 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.11 0.009 DBMET01480 0.11 0.009 DBMET01481 | DBMET01481 | |
| 0.142 | 0.044 | 0.194 | Cystathionine beta-synthase inhibitor | 0.194 0.026 DBMET01480 0.194 0.026 DBMET01481 | DBMET01481 | |
| 0.108 | 0.013 | 0.108 | NMDA receptor glycine site agonist | 0.097 0.018 DBMET01480 0.097 0.018 DBMET01481 | ||
| 0.115 | 0.021 | 0.125 | Glycine receptor antagonist | 0.125 0.015 DBMET01480 0.125 0.015 DBMET01481 | DBMET01481 | |
| 0.098 | 0.005 | 0.098 | Histone deacetylase class IV inhibitor | |||
| 0.098 | 0.005 | 0.098 | Histone deacetylase 11 inhibitor | |||
| 0.125 | 0.035 | 0.145 | Anabolic | 0.145 0.021 DBMET01480 0.145 0.021 DBMET01481 | DBMET01481 | |
| 0.121 | 0.03 | 0.133 | Lanosterol 14 alpha demethylase inhibitor | 0.133 0.019 DBMET01480 0.133 0.019 DBMET01481 | DBMET01481 | |
| 0.142 | 0.052 | 0.162 | Aldehyde dehydrogenase inhibitor | 0.162 0.041 DBMET01480 0.162 0.041 DBMET01481 | DBMET01481 | |
| 0.094 | 0.004 | 0.094 | ADAM10 endopeptidase inhibitor | |||
| 0.103 | 0.014 | 0.139 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.139 0.009 DBMET01480 0.139 0.009 DBMET01481 | DBMET01481 | |
| 0.094 | 0.005 | 0.094 | Histone deacetylase 10 inhibitor | |||
| 0.106 | 0.017 | 0.106 | NMDA receptor agonist | 0.092 0.023 DBMET01480 0.092 0.023 DBMET01481 | ||
| 0.176 | 0.089 | 0.428 | Anesthetic general | 0.25 0.05 DBMET01480 0.428 0.013 DBMET01481 | DBMET01481 | |
| 0.096 | 0.009 | 0.127 | Aconitate hydratase inhibitor | 0.127 0.005 DBMET01480 0.127 0.005 DBMET01481 | DBMET01481 | |
| 0.093 | 0.008 | 0.093 | Histone deacetylase 3 inhibitor | |||
| 0.104 | 0.019 | 0.111 | Glycine receptor agonist | 0.111 0.015 DBMET01480 0.111 0.015 DBMET01481 | DBMET01481 | |
| 0.111 | 0.028 | 0.192 | Histidine decarboxylase inhibitor | 0.192 0.014 DBMET01480 0.192 0.014 DBMET01481 | DBMET01481 | |
| 0.154 | 0.073 | 0.177 | Interferon gamma antagonist | 0.177 0.052 DBMET01480 0.177 0.052 DBMET01481 | DBMET01481 | |
| 0.087 | 0.009 | 0.087 | Kainate receptor antagonist | |||
| 0.126 | 0.05 | 0.148 | Photosensitizer | 0.148 0.032 DBMET01480 0.148 0.032 DBMET01481 | DBMET01481 | |
| 0.24 | 0.163 | 0.388 | Histamine release inhibitor | 0.388 0.082 DBMET01480 0.388 0.082 DBMET01481 | DBMET01481 | |
| 0.102 | 0.027 | 0.126 | Aminopeptidase I inhibitor | 0.126 0.018 DBMET01480 0.126 0.018 DBMET01481 | DBMET01481 | |
| 0.151 | 0.075 | 0.261 | CF transmembrane conductance regulator agonist | 0.193 0.026 DBMET01480 0.261 0.005 DBMET01481 | DBMET01481 | |
| 0.082 | 0.007 | 0.082 | Histone deacetylase 4 inhibitor | |||
| 0.12 | 0.045 | 0.12 | Urease inhibitor | 0.109 0.057 DBMET01480 0.109 0.057 DBMET01481 | ||
| 0.104 | 0.029 | 0.13 | Granulocyte macrophage colony stimulating factor agonist | 0.13 0.011 DBMET01480 0.13 0.011 DBMET01481 | DBMET01481 | |
| 0.136 | 0.065 | 0.136 | Death-associated protein kinase 1 inhibitor | |||
| 0.099 | 0.03 | 0.116 | D-Ala-D-Ala ligase inhibitor | 0.116 0.015 DBMET01480 0.116 0.015 DBMET01481 | DBMET01481 | |
| 0.099 | 0.032 | 0.105 | Na+ K+ transporting ATPase inhibitor | 0.105 0.027 DBMET01480 0.105 0.027 DBMET01481 | DBMET01481 | |
| 0.086 | 0.019 | 0.103 | Glutamate (mGluR6) antagonist | 0.103 0.009 DBMET01480 0.103 0.009 DBMET01481 | DBMET01481 | |
| 0.11 | 0.045 | 0.155 | Electrolyte absorption antagonist | 0.155 0.018 DBMET01480 0.155 0.018 DBMET01481 | DBMET01481 | |
| 0.076 | 0.011 | 0.076 | Ryanodine receptor antagonist | 0.075 0.012 DBMET01480 0.075 0.012 DBMET01481 | ||
| 0.069 | 0.005 | 0.075 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.075 0.004 DBMET01480 0.075 0.004 DBMET01481 | DBMET01481 | |
| 0.129 | 0.064 | 0.175 | Cathepsin H inhibitor | 0.175 0.032 DBMET01480 0.175 0.032 DBMET01481 | DBMET01481 | |
| 0.148 | 0.084 | 0.159 | Melanin inhibitor | 0.159 0.071 DBMET01480 0.159 0.071 DBMET01481 | DBMET01481 | |
| 0.086 | 0.022 | 0.119 | Purinergic P2X1 antagonist | 0.119 0.012 DBMET01480 0.119 0.012 DBMET01481 | DBMET01481 | |
| 0.084 | 0.02 | 0.11 | Ornithine carbamoyltransferase inhibitor | 0.11 0.014 DBMET01480 0.11 0.014 DBMET01481 | DBMET01481 | |
| 0.089 | 0.026 | 0.102 | GABA B receptor agonist | 0.102 0.015 DBMET01480 0.102 0.015 DBMET01481 | DBMET01481 | |
| 0.075 | 0.013 | 0.077 | Dihydroorotate oxidase inhibitor | 0.077 0.012 DBMET01480 0.077 0.012 DBMET01481 | DBMET01481 | |
| 0.071 | 0.01 | 0.071 | Immunoglobulin Fc receptor antagonist | 0.066 0.015 DBMET01480 0.066 0.015 DBMET01481 | ||
| 0.154 | 0.094 | 0.173 | ATPase inhibitor | 0.173 0.067 DBMET01480 0.173 0.067 DBMET01481 | DBMET01481 | |
| 0.093 | 0.035 | 0.107 | Estrogen-related receptor beta agonist | 0.107 0.018 DBMET01480 0.107 0.018 DBMET01481 | DBMET01481 | |
| 0.152 | 0.096 | 0.183 | Neurotensin receptor agonist | 0.183 0.047 DBMET01480 0.183 0.047 DBMET01481 | DBMET01481 | |
| 0.065 | 0.009 | 0.091 | Fumarate hydratase inhibitor | 0.091 0.006 DBMET01480 0.091 0.006 DBMET01481 | DBMET01481 | |
| 0.086 | 0.03 | 0.108 | Vanilloid 4 agonist | 0.108 0.011 DBMET01480 0.108 0.011 DBMET01481 | DBMET01481 | |
| 0.068 | 0.013 | 0.077 | Adenylate cyclase 1 inhibitor | 0.077 0.009 DBMET01480 0.077 0.009 DBMET01481 | DBMET01481 | |
| 0.214 | 0.16 | 0.528 | Vasodilator, peripheral | 0.303 0.095 DBMET01480 0.528 0.023 DBMET01481 | DBMET01481 | |
| 0.104 | 0.051 | 0.157 | HIV-1 integrase (Overall Integration) inhibitor | 0.157 0.023 DBMET01480 0.157 0.023 DBMET01481 | DBMET01481 | |
| 0.061 | 0.007 | 0.076 | Glutamate (mGluR8) agonist | 0.076 0.004 DBMET01480 0.076 0.004 DBMET01481 | DBMET01481 | |
| 0.104 | 0.051 | 0.148 | Prolactin inhibitor | 0.148 0.023 DBMET01480 0.148 0.023 DBMET01481 | DBMET01481 | |
| 0.063 | 0.012 | 0.063 | Glutamate (mGluR4) antagonist | 0.058 0.015 DBMET01480 0.058 0.015 DBMET01481 | ||
| 0.113 | 0.062 | 0.186 | 5 Hydroxytryptamine 3A agonist | 0.186 0.019 DBMET01480 0.186 0.019 DBMET01481 | DBMET01481 | |
| 0.094 | 0.043 | 0.096 | Carbonic anhydrase VI inhibitor | 0.096 0.042 DBMET01480 0.096 0.042 DBMET01481 | DBMET01481 | |
| 0.078 | 0.028 | 0.108 | Exportin-1 inhibitor | 0.108 0.006 DBMET01480 0.108 0.006 DBMET01481 | DBMET01481 | |
| 0.073 | 0.023 | 0.076 | Potassium channel intermediate-conductance Ca-activated blocker | 0.076 0.02 DBMET01480 0.076 0.02 DBMET01481 | DBMET01481 | |
| 0.068 | 0.018 | 0.084 | Alpha-mannosidase inhibitor | 0.084 0.01 DBMET01480 0.084 0.01 DBMET01481 | DBMET01481 | |
| 0.183 | 0.134 | 0.309 | Spasmolytic | 0.309 0.067 DBMET01481 | DBMET01481 | |
| 0.059 | 0.01 | 0.059 | Acid-sensing ion channel blocker | |||
| 0.09 | 0.041 | 0.127 | CYP2A6 inhibitor | 0.127 0.024 DBMET01480 0.127 0.024 DBMET01481 | DBMET01481 | |
| 0.073 | 0.026 | 0.163 | Carbonic anhydrase VB inhibitor | 0.075 0.025 DBMET01480 0.163 0.008 DBMET01481 | DBMET01481 | |
| 0.077 | 0.031 | 0.102 | Glutamate (mGluR7) antagonist | 0.102 0.01 DBMET01480 0.102 0.01 DBMET01481 | DBMET01481 | |
| 0.135 | 0.09 | 0.167 | Diuretic | 0.167 0.063 DBMET01481 | DBMET01481 | |
| 0.055 | 0.01 | 0.067 | Kainate receptor agonist | 0.067 0.005 DBMET01480 0.067 0.005 DBMET01481 | DBMET01481 | |
| 0.137 | 0.092 | 0.137 | MAP kinase 3 inhibitor | 0.132 0.103 DBMET01480 0.132 0.103 DBMET01481 | ||
| 0.057 | 0.013 | 0.076 | Dopamine D5 agonist | 0.076 0.007 DBMET01480 0.076 0.007 DBMET01481 | DBMET01481 | |
| 0.044 | 0.005 | 0.044 | Purinergic P2Y15 antagonist | 0.044 0.005 DBMET01480 0.044 0.005 DBMET01481 | ||
| 0.084 | 0.045 | 0.152 | Catalase inhibitor | 0.152 0.026 DBMET01480 0.152 0.026 DBMET01481 | DBMET01481 | |
| 0.133 | 0.094 | 0.167 | Sphingosine 1-phosphate receptor 5 antagonist | 0.167 0.037 DBMET01480 0.167 0.037 DBMET01481 | DBMET01481 | |
| 0.111 | 0.073 | 0.136 | Microtubule formation inhibitor | 0.136 0.046 DBMET01480 0.136 0.046 DBMET01481 | DBMET01481 | |
| 0.054 | 0.017 | 0.066 | Guanylate cyclase inhibitor | 0.066 0.007 DBMET01480 0.066 0.007 DBMET01481 | DBMET01481 | |
| 0.056 | 0.02 | 0.073 | Mannosidase inhibitor | 0.073 0.011 DBMET01480 0.073 0.011 DBMET01481 | DBMET01481 | |
| 0.056 | 0.02 | 0.062 | Dopamine beta hydroxylase inhibitor | 0.062 0.013 DBMET01480 0.062 0.013 DBMET01481 | DBMET01481 | |
| 0.16 | 0.124 | 0.213 | Neurotrophic factor enhancer | 0.213 0.065 DBMET01480 0.213 0.065 DBMET01481 | DBMET01481 | |
| 0.053 | 0.018 | 0.053 | Glutamate (mGluR group III) antagonist | 0.052 0.019 DBMET01480 0.052 0.019 DBMET01481 | ||
| 0.062 | 0.027 | 0.076 | Pregnane X receptor antagonist | 0.076 0.009 DBMET01480 0.076 0.009 DBMET01481 | DBMET01481 | |
| 0.049 | 0.015 | 0.049 | Aggrecanase 1 inhibitor | |||
| 0.116 | 0.082 | 0.219 | Cyclooxygenase 3 inhibitor | 0.161 0.039 DBMET01480 0.219 0.013 DBMET01481 | DBMET01481 | |
| 0.115 | 0.082 | 0.13 | DNA repair enzyme inhibitor | 0.13 0.055 DBMET01480 0.13 0.055 DBMET01481 | DBMET01481 | |
| 0.064 | 0.032 | 0.064 | Botulinum neurotoxin type A inhibitor | 0.056 0.043 DBMET01480 0.056 0.043 DBMET01481 | ||
| 0.091 | 0.059 | 0.125 | Glutamate release inhibitor | 0.125 0.019 DBMET01480 0.125 0.019 DBMET01481 | DBMET01481 | |
| 0.144 | 0.112 | 0.229 | 3C-like protease (Human coronavirus) inhibitor | 0.229 0.037 DBMET01480 0.229 0.037 DBMET01481 | DBMET01481 | |
| 0.11 | 0.079 | 0.122 | Transcription factor STAT6 inhibitor | 0.122 0.057 DBMET01480 0.122 0.057 DBMET01481 | DBMET01481 | |
| 0.083 | 0.053 | 0.103 | CC chemokine 5 receptor agonist | 0.103 0.019 DBMET01480 0.103 0.019 DBMET01481 | DBMET01481 | |
| 0.182 | 0.152 | 0.264 | 5 Hydroxytryptamine 1E antagonist | 0.264 0.06 DBMET01480 0.264 0.06 DBMET01481 | DBMET01481 | |
| 0.047 | 0.018 | 0.049 | Membrane dipeptidase inhibitor | 0.049 0.016 DBMET01480 0.049 0.016 DBMET01481 | DBMET01481 | |
| 0.04 | 0.012 | 0.054 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.054 0.008 DBMET01480 0.054 0.008 DBMET01481 | DBMET01481 | |
| 0.079 | 0.051 | 0.086 | Carbonic anhydrase XIII inhibitor | 0.086 0.046 DBMET01480 0.086 0.046 DBMET01481 | DBMET01481 | |
| 0.106 | 0.078 | 0.13 | TRPA1 agonist | 0.13 0.048 DBMET01480 0.13 0.048 DBMET01481 | DBMET01481 | |
| 0.078 | 0.051 | 0.091 | MAP kinase kinase 7 inhibitor | 0.091 0.022 DBMET01480 0.091 0.022 DBMET01481 | DBMET01481 | |
| 0.077 | 0.051 | 0.104 | GABA aminotransferase inhibitor | 0.104 0.024 DBMET01480 0.104 0.024 DBMET01481 | DBMET01481 | |
| 0.054 | 0.029 | 0.068 | Lysophosphatidic acid 3 receptor antagonist | 0.068 0.015 DBMET01480 0.068 0.015 DBMET01481 | DBMET01481 | |
| 0.073 | 0.048 | 0.097 | Phospholipase D inhibitor | 0.097 0.016 DBMET01480 0.097 0.016 DBMET01481 | DBMET01481 | |
| 0.119 | 0.094 | 0.142 | Protein kinase stimulant | 0.142 0.074 DBMET01480 0.142 0.074 DBMET01481 | DBMET01481 | |
| 0.069 | 0.044 | 0.158 | Carbonic anhydrase V inhibitor | 0.073 0.04 DBMET01480 0.158 0.013 DBMET01481 | DBMET01481 | |
| 0.052 | 0.028 | 0.057 | Adenosine deaminase inhibitor | 0.057 0.024 DBMET01480 0.057 0.024 DBMET01481 | DBMET01481 | |
| 0.103 | 0.08 | 0.143 | Acetylcholine release stimulant | 0.143 0.021 DBMET01480 0.143 0.021 DBMET01481 | DBMET01481 | |
| 0.036 | 0.014 | 0.039 | Glutamate (mGluR3) agonist | 0.039 0.01 DBMET01480 0.039 0.01 DBMET01481 | DBMET01481 | |
| 0.064 | 0.042 | 0.079 | Transcription factor RelA inhibitor | 0.079 0.018 DBMET01480 0.079 0.018 DBMET01481 | DBMET01481 | |
| 0.12 | 0.098 | 0.151 | Sphingosine 1-phosphate receptor 2 antagonist | 0.151 0.039 DBMET01480 0.151 0.039 DBMET01481 | DBMET01481 | |
| 0.132 | 0.111 | 0.153 | Heat shock protein 70 antagonist | 0.153 0.04 DBMET01480 0.153 0.04 DBMET01481 | DBMET01481 | |
| 0.045 | 0.025 | 0.061 | Nerve growth factor antagonist | 0.061 0.009 DBMET01480 0.061 0.009 DBMET01481 | DBMET01481 | |
| 0.138 | 0.118 | 0.145 | DNA methyltransferase I inhibitor | 0.145 0.11 DBMET01480 0.145 0.11 DBMET01481 | DBMET01481 | |
| 0.041 | 0.022 | 0.044 | Arginase inhibitor | 0.044 0.019 DBMET01480 0.044 0.019 DBMET01481 | DBMET01481 | |
| 0.03 | 0.011 | 0.031 | Thymidine phosphorylase inhibitor | 0.031 0.011 DBMET01480 0.031 0.011 DBMET01481 | DBMET01481 | |
| 0.067 | 0.049 | 0.077 | Carbonic anhydrase VA inhibitor | 0.077 0.039 DBMET01480 0.077 0.039 DBMET01481 | DBMET01481 | |
| 0.029 | 0.012 | 0.035 | Vanilloid 2 agonist | 0.035 0.005 DBMET01480 0.035 0.005 DBMET01481 | DBMET01481 | |
| 0.021 | 0.004 | 0.021 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.017 0.005 DBMET01480 0.017 0.005 DBMET01481 | ||
| 0.028 | 0.012 | 0.034 | Complement factor 1s inhibitor | 0.034 0.005 DBMET01480 0.034 0.005 DBMET01481 | DBMET01481 | |
| 0.093 | 0.078 | 0.13 | Carbonic anhydrase XV inhibitor | 0.13 0.04 DBMET01480 0.13 0.04 DBMET01481 | DBMET01481 | |
| 0.033 | 0.019 | 0.033 | Peptide deformylase inhibitor | |||
| 0.097 | 0.083 | 0.131 | Mucolytic | 0.131 0.045 DBMET01480 0.131 0.045 DBMET01481 | DBMET01481 | |
| 0.021 | 0.007 | 0.032 | Carbonic anhydrase X inhibitor | 0.032 0.004 DBMET01480 0.032 0.004 DBMET01481 | DBMET01481 | |
| 0.021 | 0.007 | 0.032 | Carbonic anhydrase VIII inhibitor | 0.032 0.004 DBMET01480 0.032 0.004 DBMET01481 | DBMET01481 | |
| 0.03 | 0.016 | 0.036 | Estrogen-related receptor gamma antagonist | 0.036 0.007 DBMET01480 0.036 0.007 DBMET01481 | DBMET01481 | |
| 0.04 | 0.026 | 0.07 | Alpha 1d adrenoreceptor agonist | 0.07 0.007 DBMET01480 0.07 0.007 DBMET01481 | DBMET01481 | |
| 0.099 | 0.085 | 0.1 | Adenylate cyclase inhibitor | 0.1 0.085 DBMET01480 0.1 0.085 DBMET01481 | DBMET01481 | |
| 0.02 | 0.007 | 0.024 | Telomerase stimulant | 0.024 0.004 DBMET01480 0.024 0.004 DBMET01481 | DBMET01481 | |
| 0.023 | 0.01 | 0.023 | Retinoid X beta receptor antagonist | 0.022 0.011 DBMET01480 0.022 0.011 DBMET01481 | ||
| 0.03 | 0.018 | 0.047 | Uridine phosphorylase inhibitor | 0.047 0.009 DBMET01480 0.047 0.009 DBMET01481 | DBMET01481 | |
| 0.104 | 0.092 | 0.189 | Amylase inhibitor | 0.189 0.048 DBMET01480 0.189 0.048 DBMET01481 | DBMET01481 | |
| 0.043 | 0.032 | 0.057 | AICAR transformylase inhibitor | 0.057 0.016 DBMET01480 0.057 0.016 DBMET01481 | DBMET01481 | |
| 0.039 | 0.028 | 0.042 | AMPA 4 receptor antagonist | 0.042 0.023 DBMET01480 0.042 0.023 DBMET01481 | DBMET01481 | |
| 0.031 | 0.019 | 0.041 | Nicotinic alpha3beta4 receptor agonist | 0.041 0.009 DBMET01480 0.041 0.009 DBMET01481 | DBMET01481 | |
| 0.032 | 0.021 | 0.037 | Potassium channel small-conductance Ca-activated activator | 0.037 0.017 DBMET01480 0.037 0.017 DBMET01481 | DBMET01481 | |
| 0.182 | 0.171 | 0.182 | 12-Lipoxygenase inhibitor | |||
| 0.042 | 0.031 | 0.068 | Histamine H2 receptor agonist | 0.068 0.011 DBMET01480 0.068 0.011 DBMET01481 | DBMET01481 | |
| 0.02 | 0.009 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET01480 0.022 0.006 DBMET01481 | DBMET01481 | |
| 0.025 | 0.017 | 0.032 | Lysophosphatidic acid receptor 1 agonist | 0.032 0.01 DBMET01480 0.032 0.01 DBMET01481 | DBMET01481 | |
| 0.092 | 0.084 | 0.103 | Beta glucuronidase inhibitor | 0.103 0.066 DBMET01480 0.103 0.066 DBMET01481 | DBMET01481 | |
| 0.023 | 0.015 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.026 0.01 DBMET01480 0.026 0.01 DBMET01481 | DBMET01481 | |
| 0.014 | 0.006 | 0.02 | Glutamate (mGluR6) agonist | 0.02 0.004 DBMET01480 0.02 0.004 DBMET01481 | DBMET01481 | |
| 0.038 | 0.03 | 0.053 | GABA uptake inhibitor | 0.053 0.014 DBMET01480 0.053 0.014 DBMET01481 | DBMET01481 | |
| 0.042 | 0.034 | 0.051 | Heme oxygenase inhibitor | 0.051 0.012 DBMET01480 0.051 0.012 DBMET01481 | DBMET01481 | |
| 0.027 | 0.019 | 0.034 | Hedgehog signaling activator | 0.034 0.008 DBMET01480 0.034 0.008 DBMET01481 | DBMET01481 | |
| 0.077 | 0.07 | 0.122 | Histamine N-methyltransferase inhibitor | 0.122 0.028 DBMET01480 0.122 0.028 DBMET01481 | DBMET01481 | |
| 0.016 | 0.009 | 0.022 | Thromboxane A2 agonist | 0.022 0.005 DBMET01480 0.022 0.005 DBMET01481 | DBMET01481 | |
| 0.038 | 0.03 | 0.056 | Dihydropteroate synthase inhibitor | 0.056 0.013 DBMET01480 0.056 0.013 DBMET01481 | DBMET01481 | |
| 0.024 | 0.017 | 0.03 | Glutamate (mGluR1) agonist | 0.03 0.009 DBMET01480 0.03 0.009 DBMET01481 | DBMET01481 | |
| 0.016 | 0.009 | 0.02 | Purinergic P2Y1 agonist | 0.02 0.007 DBMET01480 0.02 0.007 DBMET01481 | DBMET01481 | |
| 0.059 | 0.052 | 0.092 | Phosphodiesterase 1C inhibitor | 0.092 0.013 DBMET01481 | DBMET01481 | |
| 0.041 | 0.035 | 0.057 | Geranyltranstransferase inhibitor | 0.057 0.016 DBMET01480 0.057 0.016 DBMET01481 | DBMET01481 | |
| 0.039 | 0.033 | 0.054 | Oxytocin agonist | 0.054 0.021 DBMET01480 0.054 0.021 DBMET01481 | DBMET01481 | |
| 0.041 | 0.036 | 0.056 | Histamine H1 receptor agonist | 0.056 0.012 DBMET01480 0.056 0.012 DBMET01481 | DBMET01481 | |
| 0.07 | 0.065 | 0.092 | Keratolytic | 0.092 0.036 DBMET01480 0.092 0.036 DBMET01481 | DBMET01481 | |
| 0.014 | 0.009 | 0.02 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 DBMET01480 0.02 0.005 DBMET01481 | DBMET01481 | |
| 0.032 | 0.027 | 0.035 | Retinoid X alpha receptor antagonist | 0.035 0.023 DBMET01480 0.035 0.023 DBMET01481 | DBMET01481 | |
| 0.036 | 0.031 | 0.039 | Retinoid X receptor antagonist | 0.039 0.025 DBMET01480 0.039 0.025 DBMET01481 | DBMET01481 | |
| 0.107 | 0.102 | 0.144 | Sphingosine 1-phosphate receptor 4 antagonist | 0.144 0.039 DBMET01480 0.144 0.039 DBMET01481 | DBMET01481 | |
| 0.036 | 0.033 | 0.036 | Histone deacetylase 9 inhibitor | |||
| 0.057 | 0.054 | 0.057 | Neutrophil collagenase inhibitor | |||
| 0.048 | 0.046 | 0.067 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.067 0.024 DBMET01480 0.067 0.024 DBMET01481 | DBMET01481 | |
| 0.025 | 0.023 | 0.034 | Nicotinic acid receptor 2 antagonist | 0.034 0.009 DBMET01480 0.034 0.009 DBMET01481 | DBMET01481 | |
| 0.046 | 0.045 | 0.101 | Potassium channel (Inward rectifier) activator | 0.064 0.016 DBMET01480 0.101 0.004 DBMET01481 | DBMET01481 | |
| 0.02 | 0.019 | 0.036 | Glutamate (mGluR1a) agonist | 0.036 0.007 DBMET01480 0.036 0.007 DBMET01481 | DBMET01481 | |
| 0.044 | 0.043 | 0.098 | Potassium channel (ATP-sensitive) activator | 0.061 0.015 DBMET01480 0.098 0.004 DBMET01481 | DBMET01481 | |
| 0.095 | 0.094 | 0.129 | Cholesterol synthesis inhibitor | 0.129 0.057 DBMET01480 0.129 0.057 DBMET01481 | DBMET01481 | |
| 0.153 | 0.152 | 0.167 | Immunostimulant | 0.167 0.141 DBMET01480 0.167 0.141 DBMET01481 | DBMET01481 | |
| 0.049 | 0.049 | 0.063 | Sphingosine kinase 2 inhibitor | 0.063 0.028 DBMET01480 0.063 0.028 DBMET01481 | DBMET01481 | |
| 0.06 | 0.06 | 0.075 | Calcium channel P-type blocker | 0.075 0.02 DBMET01480 0.075 0.02 DBMET01481 | DBMET01481 | |
| 0.011 | 0.011 | 0.017 | Carbonic anhydrase XI inhibitor | 0.017 0.005 DBMET01480 0.017 0.005 DBMET01481 | DBMET01481 | |
| 0.025 | 0.026 | 0.036 | Nicotinic alpha4beta2 receptor agonist | 0.036 0.011 DBMET01480 0.036 0.011 DBMET01481 | DBMET01481 | |
| 0.088 | 0.089 | 0.119 | Glutamate (mGluR7) agonist | 0.119 0.031 DBMET01480 0.119 0.031 DBMET01481 | DBMET01481 | |
| 0.073 | 0.074 | 0.095 | Glutathione S-transferase inhibitor | 0.095 0.042 DBMET01480 0.095 0.042 DBMET01481 | DBMET01481 | |
| 0.073 | 0.075 | 0.095 | Ornithine decarboxylase inhibitor | 0.095 0.05 DBMET01480 0.095 0.05 DBMET01481 | DBMET01481 | |
| 0.017 | 0.02 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 DBMET01480 0.021 0.009 DBMET01481 | DBMET01481 | |
| 0.076 | 0.079 | 0.102 | mTOR complex 2 inhibitor | 0.102 0.031 DBMET01480 0.102 0.031 DBMET01481 | DBMET01481 | |
| 0.029 | 0.033 | 0.043 | Phosphoglycerate kinase inhibitor | 0.043 0.018 DBMET01480 0.043 0.018 DBMET01481 | DBMET01481 | |
| 0.11 | 0.114 | 0.133 | Vanilloid 1 agonist | 0.133 0.061 DBMET01480 0.133 0.061 DBMET01481 | DBMET01481 | |
| 0.006 | 0.009 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.004 DBMET01480 0.008 0.004 DBMET01481 | DBMET01481 | |
| 0.022 | 0.026 | 0.029 | Lysine carboxypeptidase inhibitor | 0.029 0.017 DBMET01480 0.029 0.017 DBMET01481 | DBMET01481 | |
| 0.008 | 0.012 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 DBMET01480 0.01 0.009 DBMET01481 | DBMET01481 | |
| 0.018 | 0.023 | 0.023 | Neuraminidase (Influenza B) inhibitor | 0.023 0.011 DBMET01480 0.023 0.011 DBMET01481 | DBMET01481 | |
| 0.044 | 0.049 | 0.053 | Cytokine production stimulant | 0.053 0.022 DBMET01480 0.053 0.022 DBMET01481 | DBMET01481 | |
| 0.064 | 0.069 | 0.074 | Metalloproteinase-9 inhibitor | 0.074 0.049 DBMET01481 | DBMET01481 | |
| 0.024 | 0.03 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 DBMET01480 0.029 0.013 DBMET01481 | DBMET01481 | |
| 0.031 | 0.037 | 0.041 | Glutamate (mGluR3) antagonist | 0.041 0.02 DBMET01480 0.041 0.02 DBMET01481 | DBMET01481 | |
| 0.032 | 0.039 | 0.044 | Toll-Like receptor 2 agonist | 0.044 0.026 DBMET01480 0.044 0.026 DBMET01481 | DBMET01481 | |
| 0.018 | 0.025 | 0.024 | Prostaglandin F2 alpha agonist | 0.024 0.014 DBMET01480 0.024 0.014 DBMET01481 | DBMET01481 | |
| 0.054 | 0.061 | 0.072 | 5 Hydroxytryptamine 3 agonist | 0.072 0.034 DBMET01480 0.072 0.034 DBMET01481 | DBMET01481 | |
| 0.13 | 0.138 | 0.141 | DNA methylase inhibitor | 0.141 0.126 DBMET01480 0.141 0.126 DBMET01481 | DBMET01481 | |
| 0.121 | 0.129 | 0.152 | Pregnane X receptor agonist | 0.152 0.05 DBMET01480 0.152 0.05 DBMET01481 | DBMET01481 | |
| 0.027 | 0.035 | 0.035 | Retinoid X alpha receptor agonist | 0.035 0.024 DBMET01480 0.035 0.024 DBMET01481 | DBMET01481 | |
| 0.026 | 0.035 | 0.039 | Kainate receptor 2 antagonist | 0.039 0.023 DBMET01480 0.039 0.023 DBMET01481 | DBMET01481 | |
| 0.042 | 0.051 | 0.049 | Bombesin 2 receptor antagonist | 0.049 0.034 DBMET01480 0.049 0.034 DBMET01481 | DBMET01481 | |
| 0.025 | 0.034 | 0.03 | Calcitonin receptor agonist | 0.03 0.027 DBMET01480 0.03 0.027 DBMET01481 | DBMET01481 | |
| 0.037 | 0.046 | 0.049 | Thymidylate synthase inhibitor | 0.049 0.029 DBMET01480 0.049 0.029 DBMET01481 | DBMET01481 | |
| 0.012 | 0.022 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 DBMET01480 0.018 0.011 DBMET01481 | DBMET01481 | |
| 0.017 | 0.027 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.01 DBMET01480 0.023 0.01 DBMET01481 | DBMET01481 | |
| 0.056 | 0.066 | 0.074 | Interferon inducer | 0.074 0.03 DBMET01480 0.074 0.03 DBMET01481 | DBMET01481 | |
| 0.098 | 0.108 | 0.137 | Toll-Like receptor 2 antagonist | 0.137 0.062 DBMET01480 0.137 0.062 DBMET01481 | DBMET01481 | |
| 0.007 | 0.017 | 0.01 | Thromboxane agonist | 0.01 0.009 DBMET01480 0.01 0.009 DBMET01481 | DBMET01481 | |
| 0.043 | 0.053 | 0.059 | Squalene epoxidase inhibitor | 0.059 0.021 DBMET01480 0.059 0.021 DBMET01481 | DBMET01481 | |
| 0.004 | 0.015 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET01480 0.006 0.005 DBMET01481 | DBMET01481 | |
| 0.032 | 0.043 | 0.068 | Carbonic anhydrase IV inhibitor | 0.068 0.015 DBMET01481 | DBMET01481 | |
| 0.004 | 0.015 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 DBMET01480 0.006 0.005 DBMET01481 | DBMET01481 | |
| 0.054 | 0.066 | 0.077 | Protease 3C (Human rhinovirus) inhibitor | 0.077 0.029 DBMET01480 0.077 0.029 DBMET01481 | DBMET01481 | |
| 0.09 | 0.101 | 0.183 | Alkylator | 0.12 0.068 DBMET01480 0.183 0.032 DBMET01481 | DBMET01481 | |
| 0.013 | 0.024 | 0.019 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 DBMET01480 0.019 0.01 DBMET01481 | DBMET01481 | |
| 0.025 | 0.037 | 0.032 | Methionyl aminopeptidase 1 inhibitor | 0.032 0.023 DBMET01480 0.032 0.023 DBMET01481 | DBMET01481 | |
| 0.071 | 0.083 | 0.081 | Myeloperoxidase inhibitor | 0.081 0.065 DBMET01480 0.081 0.065 DBMET01481 | DBMET01481 | |
| 0.036 | 0.048 | 0.053 | Fructose-1,6-bisphosphatase inhibitor | 0.053 0.022 DBMET01480 0.053 0.022 DBMET01481 | DBMET01481 | |
| 0.036 | 0.048 | 0.044 | GABA B receptor antagonist | 0.044 0.028 DBMET01480 0.044 0.028 DBMET01481 | DBMET01481 | |
| 0.024 | 0.036 | 0.03 | Retinoid X receptor agonist | 0.03 0.029 DBMET01480 0.03 0.029 DBMET01481 | DBMET01481 | |
| 0.024 | 0.037 | 0.031 | MAP3K8 inhibitor | 0.031 0.016 DBMET01480 0.031 0.016 DBMET01481 | DBMET01481 | |
| 0.034 | 0.046 | 0.045 | Thymidine kinase inhibitor | 0.045 0.023 DBMET01480 0.045 0.023 DBMET01481 | DBMET01481 | |
| 0.03 | 0.043 | 0.036 | Vascular adhesion protein 1 inhibitor | 0.036 0.031 DBMET01480 0.036 0.031 DBMET01481 | DBMET01481 | |
| 0.017 | 0.03 | 0.023 | Factor XIII inhibitor | 0.023 0.01 DBMET01480 0.023 0.01 DBMET01481 | DBMET01481 | |
| 0.018 | 0.032 | 0.026 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.026 0.012 DBMET01480 0.026 0.012 DBMET01481 | DBMET01481 | |
| 0.028 | 0.041 | 0.033 | Glutamate (mGluR4) agonist | 0.033 0.025 DBMET01480 0.033 0.025 DBMET01481 | DBMET01481 | |
| 0.052 | 0.066 | 0.099 | Sphingosine 1-phosphate receptor 4 agonist | 0.099 0.026 DBMET01480 0.099 0.026 DBMET01481 | DBMET01481 | |
| 0.005 | 0.019 | 0.009 | Progesterone receptor A antagonist | 0.009 0.007 DBMET01480 0.009 0.007 DBMET01481 | DBMET01481 | |
| 0.06 | 0.074 | 0.091 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.091 0.043 DBMET01480 0.091 0.043 DBMET01481 | DBMET01481 | |
| 0.031 | 0.046 | 0.048 | Potassium channel Kv1.1 blocker | 0.048 0.014 DBMET01480 0.048 0.014 DBMET01481 | DBMET01481 | |
| 0.061 | 0.075 | 0.077 | MDM2 inhibitor | 0.077 0.025 DBMET01480 0.077 0.025 DBMET01481 | DBMET01481 | |
| 0.045 | 0.06 | 0.065 | Nicotinic alpha3beta2 receptor antagonist | 0.065 0.021 DBMET01480 0.065 0.021 DBMET01481 | DBMET01481 | |
| 0.021 | 0.036 | 0.03 | Acid ceramidase inhibitor | 0.03 0.009 DBMET01480 0.03 0.009 DBMET01481 | DBMET01481 | |
| 0.021 | 0.036 | 0.028 | Integrin alpha2beta1 antagonist | 0.028 0.015 DBMET01480 0.028 0.015 DBMET01481 | DBMET01481 | |
| 0.011 | 0.028 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.012 DBMET01480 0.016 0.012 DBMET01481 | DBMET01481 | |
| 0.029 | 0.046 | 0.04 | Integrin alpha2 antagonist | 0.04 0.021 DBMET01480 0.04 0.021 DBMET01481 | DBMET01481 | |
| 0.047 | 0.064 | 0.07 | Androgen agonist | 0.07 0.031 DBMET01480 0.07 0.031 DBMET01481 | DBMET01481 | |
| 0.011 | 0.029 | 0.021 | Cyclin T1 inhibitor | 0.021 0.01 DBMET01480 0.021 0.01 DBMET01481 | DBMET01481 | |
| 0.046 | 0.064 | 0.066 | Carbonic anhydrase stimulant | 0.066 0.035 DBMET01480 0.066 0.035 DBMET01481 | DBMET01481 | |
| 0.062 | 0.081 | 0.073 | Metalloproteinase-2 inhibitor | 0.073 0.06 DBMET01481 | DBMET01481 | |
| 0.144 | 0.164 | 0.192 | Cyclic AMP phosphodiesterase inhibitor | 0.192 0.1 DBMET01480 0.192 0.1 DBMET01481 | DBMET01481 | |
| 0.019 | 0.039 | 0.041 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.02 DBMET01480 0.041 0.008 DBMET01481 | DBMET01481 | |
| 0.027 | 0.046 | 0.039 | Diamine oxidase inhibitor | 0.039 0.024 DBMET01480 0.039 0.024 DBMET01481 | DBMET01481 | |
| 0.049 | 0.069 | 0.055 | Leukotriene C antagonist | 0.055 0.045 DBMET01480 0.055 0.045 DBMET01481 | DBMET01481 | |
| 0.073 | 0.093 | 0.11 | Alcohol dehydrogenase inhibitor | 0.11 0.042 DBMET01480 0.11 0.042 DBMET01481 | DBMET01481 | |
| 0.012 | 0.035 | 0.016 | CC chemokine 9 receptor antagonist | 0.016 0.013 DBMET01480 0.016 0.013 DBMET01481 | DBMET01481 | |
| 0.063 | 0.086 | 0.088 | Interferon agonist | 0.088 0.041 DBMET01480 0.088 0.041 DBMET01481 | DBMET01481 | |
| 0.039 | 0.061 | 0.047 | Topoisomerase II beta inhibitor | 0.047 0.038 DBMET01480 0.047 0.038 DBMET01481 | DBMET01481 | |
| 0.013 | 0.036 | 0.017 | CXC chemokine 5 receptor antagonist | 0.017 0.015 DBMET01480 0.017 0.015 DBMET01481 | DBMET01481 | |
| 0.022 | 0.046 | 0.034 | Epoxide hydrolase 1 inhibitor | 0.034 0.016 DBMET01480 0.034 0.016 DBMET01481 | DBMET01481 | |
| 0.048 | 0.072 | 0.096 | Acetylcholine M5 receptor agonist | 0.096 0.023 DBMET01480 0.096 0.023 DBMET01481 | DBMET01481 | |
| 0.01 | 0.034 | 0.013 | Cyclin D2 inhibitor | 0.013 0.01 DBMET01480 0.013 0.01 DBMET01481 | DBMET01481 | |
| 0.031 | 0.057 | 0.043 | Glutamate (mGluR group III) agonist | 0.043 0.03 DBMET01480 0.043 0.03 DBMET01481 | DBMET01481 | |
| 0.029 | 0.055 | 0.038 | Adenosine uptake inhibitor | 0.038 0.016 DBMET01480 0.038 0.016 DBMET01481 | DBMET01481 | |
| 0.031 | 0.058 | 0.042 | Vanilloid 3 antagonist | 0.042 0.018 DBMET01480 0.042 0.018 DBMET01481 | DBMET01481 | |
| 0.022 | 0.049 | 0.029 | ATP citrate lysase inhibitor | 0.029 0.027 DBMET01480 0.029 0.027 DBMET01481 | DBMET01481 | |
| 0.028 | 0.056 | 0.038 | Tryptophan 5 hydroxylase inhibitor | 0.038 0.02 DBMET01480 0.038 0.02 DBMET01481 | DBMET01481 | |
| 0.034 | 0.063 | 0.04 | CF transmembrane conductance regulator antagonist | 0.04 0.026 DBMET01480 0.04 0.026 DBMET01481 | DBMET01481 | |
| 0.043 | 0.073 | 0.061 | NMDA 2C receptor antagonist | 0.061 0.044 DBMET01480 0.061 0.044 DBMET01481 | DBMET01481 | |
| 0.022 | 0.052 | 0.034 | Free fatty acid receptor 1 antagonist | 0.034 0.023 DBMET01480 0.034 0.023 DBMET01481 | DBMET01481 | |
| 0.043 | 0.073 | 0.057 | Epithelial sodium channel blocker | 0.057 0.033 DBMET01480 0.057 0.033 DBMET01481 | DBMET01481 | |
| 0.014 | 0.046 | 0.024 | Protease (Human cytomegalovirus) inhibitor | 0.024 0.012 DBMET01480 0.024 0.012 DBMET01481 | DBMET01481 | |
| 0.042 | 0.074 | 0.052 | Thromboxane synthase inhibitor | 0.052 0.043 DBMET01481 | DBMET01481 | |
| 0.026 | 0.058 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.021 DBMET01480 0.034 0.021 DBMET01481 | DBMET01481 | |
| 0.018 | 0.051 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 DBMET01481 | DBMET01481 | |
| 0.019 | 0.055 | 0.028 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.024 DBMET01480 0.028 0.024 DBMET01481 | DBMET01481 | |
| 0.012 | 0.048 | 0.022 | Imidazoline I1 receptor antagonist | 0.022 0.012 DBMET01480 0.022 0.012 DBMET01481 | DBMET01481 | |
| 0.041 | 0.078 | 0.055 | Glucosylceramidase inhibitor | 0.055 0.038 DBMET01480 0.055 0.038 DBMET01481 | DBMET01481 | |
| 0.039 | 0.077 | 0.048 | CD45 antagonist | 0.048 0.04 DBMET01480 0.048 0.04 DBMET01481 | DBMET01481 | |
| 0.024 | 0.062 | 0.034 | Ceramide glucosyltransferase inhibitor | 0.034 0.028 DBMET01480 0.034 0.028 DBMET01481 | DBMET01481 | |
| 0.02 | 0.058 | 0.028 | 5 Hydroxytryptamine 6 agonist | 0.028 0.022 DBMET01480 0.028 0.022 DBMET01481 | DBMET01481 | |
| 0.055 | 0.094 | 0.205 | Calcium antagonist | 0.116 0.037 DBMET01480 0.205 0.013 DBMET01481 | DBMET01481 | |
| 0.071 | 0.111 | 0.102 | Expectorant | 0.102 0.066 DBMET01480 0.102 0.066 DBMET01481 | DBMET01481 | |
| 0.07 | 0.11 | 0.126 | Falcipain 3 inhibitor | 0.126 0.05 DBMET01480 0.126 0.05 DBMET01481 | DBMET01481 | |
| 0.061 | 0.101 | 0.082 | Potassium channel (Ca-activated) activator | 0.082 0.073 DBMET01480 0.082 0.073 DBMET01481 | DBMET01481 | |
| 0.04 | 0.08 | 0.057 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.057 0.042 DBMET01480 0.057 0.042 DBMET01481 | DBMET01481 | |
| 0.043 | 0.084 | 0.081 | Phosphodiesterase 1B inhibitor | 0.081 0.022 DBMET01481 | DBMET01481 | |
| 0.073 | 0.115 | 0.131 | Xanthine oxidase inhibitor | 0.085 0.08 DBMET01480 0.131 0.042 DBMET01481 | DBMET01481 | |
| 0.123 | 0.166 | 0.255 | Non-steroidal antiinflammatory agent | 0.255 0.041 DBMET01481 | DBMET01481 | |
| 0.023 | 0.067 | 0.033 | Melatonin receptor 1A agonist | 0.033 0.025 DBMET01480 0.033 0.025 DBMET01481 | DBMET01481 | |
| 0.094 | 0.14 | 0.112 | Antibacterial (Helicobacter pylori) | 0.112 0.094 DBMET01480 0.112 0.094 DBMET01481 | DBMET01481 | |
| 0.073 | 0.12 | 0.097 | Bile acid receptor antagonist | 0.097 0.057 DBMET01480 0.097 0.057 DBMET01481 | DBMET01481 | |
| 0.038 | 0.085 | 0.051 | Heparanase inhibitor | 0.051 0.041 DBMET01480 0.051 0.041 DBMET01481 | DBMET01481 | |
| 0.171 | 0.219 | 0.329 | Antithrombotic | 0.207 0.169 DBMET01480 0.329 0.073 DBMET01481 | DBMET01481 | |
| 0.028 | 0.077 | 0.041 | Dihydroorotase inhibitor | 0.041 0.037 DBMET01480 0.041 0.037 DBMET01481 | DBMET01481 | |
| 0.02 | 0.07 | 0.028 | Glucosylceramidase stimulant | 0.028 0.018 DBMET01480 0.028 0.018 DBMET01481 | DBMET01481 | |
| 0.042 | 0.092 | 0.055 | Sphingosine kinase inhibitor | 0.055 0.049 DBMET01480 0.055 0.049 DBMET01481 | DBMET01481 | |
| 0.032 | 0.083 | 0.052 | Aldosterone antagonist | 0.052 0.027 DBMET01480 0.052 0.027 DBMET01481 | DBMET01481 | |
| 0.045 | 0.096 | 0.069 | Corticotropin releasing factor 2 receptor antagonist | 0.069 0.029 DBMET01480 0.069 0.029 DBMET01481 | DBMET01481 | |
| 0.131 | 0.184 | 0.169 | Histone acetyltransferase inhibitor | 0.169 0.114 DBMET01480 0.169 0.114 DBMET01481 | DBMET01481 | |
| 0.07 | 0.123 | 0.094 | MAP kinase kinase 1 inhibitor | 0.094 0.064 DBMET01480 0.094 0.064 DBMET01481 | DBMET01481 | |
| 0.035 | 0.088 | 0.046 | HCV NS3/NS4A protease inhibitor | 0.046 0.04 DBMET01480 0.046 0.04 DBMET01481 | DBMET01481 | |
| 0.055 | 0.11 | 0.079 | Potassium channel (Tandem pore domain) blocker | 0.079 0.036 DBMET01480 0.079 0.036 DBMET01481 | DBMET01481 | |
| 0.031 | 0.087 | 0.046 | Purinergic P2X4 antagonist | 0.046 0.032 DBMET01480 0.046 0.032 DBMET01481 | DBMET01481 | |
| 0.049 | 0.105 | 0.062 | Histone deacetylase SIRT3 inhibitor | 0.062 0.044 DBMET01480 0.062 0.044 DBMET01481 | DBMET01481 | |
| 0.157 | 0.213 | 0.2 | Neuropeptide Y2 antagonist | 0.2 0.119 DBMET01480 0.2 0.119 DBMET01481 | DBMET01481 | |
| 0.023 | 0.083 | 0.036 | Delayed rectifier potassium channel blocker | 0.036 0.029 DBMET01480 0.036 0.029 DBMET01481 | DBMET01481 | |
| 0.022 | 0.083 | 0.053 | Angiotensin AT1 receptor antagonist | 0.039 0.035 DBMET01480 0.053 0.014 DBMET01481 | DBMET01481 | |
| 0.089 | 0.151 | 0.142 | Cytidine deaminase inhibitor | 0.142 0.082 DBMET01480 0.142 0.082 DBMET01481 | DBMET01481 | |
| 0.098 | 0.16 | 0.155 | Hexokinase inhibitor | 0.155 0.073 DBMET01480 0.155 0.073 DBMET01481 | DBMET01481 | |
| 0.112 | 0.175 | 0.163 | I kappa B kinase epsilon inhibitor | 0.163 0.106 DBMET01480 0.163 0.106 DBMET01481 | DBMET01481 | |
| 0.034 | 0.098 | 0.06 | Cyclin-dependent kinase 6 inhibitor | 0.06 0.041 DBMET01480 0.06 0.041 DBMET01481 | DBMET01481 | |
| 0.031 | 0.1 | 0.047 | Prolyl endopeptidase inhibitor | 0.047 0.04 DBMET01480 0.047 0.04 DBMET01481 | DBMET01481 | |
| 0.019 | 0.088 | 0.044 | Angiotensin II receptor antagonist | 0.044 0.01 DBMET01481 | DBMET01481 | |
| 0.012 | 0.081 | 0.028 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.026 DBMET01480 0.028 0.026 DBMET01481 | DBMET01481 | |
| 0.021 | 0.093 | 0.069 | Carbonic anhydrase II inhibitor | 0.069 0.03 DBMET01481 | DBMET01481 | |
| 0.022 | 0.095 | 0.05 | Thromboxane A2 antagonist | 0.05 0.036 DBMET01481 | DBMET01481 | |
| 0.034 | 0.107 | 0.055 | Sphingosine 1-phosphate receptor 3 antagonist | 0.055 0.046 DBMET01480 0.055 0.046 DBMET01481 | DBMET01481 | |
| 0.021 | 0.095 | 0.066 | Carbonic anhydrase I inhibitor | 0.066 0.031 DBMET01481 | DBMET01481 | |
| 0.042 | 0.117 | 0.066 | Cathepsin G inhibitor | 0.066 0.059 DBMET01480 0.066 0.059 DBMET01481 | DBMET01481 | |
| 0.043 | 0.119 | 0.088 | Nicotinic alpha4beta2 receptor antagonist | 0.088 0.042 DBMET01480 0.088 0.042 DBMET01481 | DBMET01481 | |
| 0.06 | 0.137 | 0.108 | Phosphodiesterase I inhibitor | 0.108 0.035 DBMET01481 | DBMET01481 | |
| 0.104 | 0.181 | 0.147 | MAP kinase kinase 2 inhibitor | 0.147 0.124 DBMET01480 0.147 0.124 DBMET01481 | DBMET01481 | |
| 0.024 | 0.102 | 0.061 | Thromboxane antagonist | 0.061 0.032 DBMET01481 | DBMET01481 | |
| 0.024 | 0.103 | 0.037 | 5 Hydroxytryptamine 2B agonist | 0.037 0.032 DBMET01480 0.037 0.032 DBMET01481 | DBMET01481 | |
| 0.062 | 0.141 | 0.089 | Bromodomain-containing protein 2 inhibitor | 0.089 0.056 DBMET01480 0.089 0.056 DBMET01481 | DBMET01481 | |
| 0.041 | 0.121 | 0.088 | Phosphodiesterase 1A inhibitor | 0.057 0.049 DBMET01480 0.088 0.013 DBMET01481 | DBMET01481 | |
| 0.036 | 0.116 | 0.053 | 5 Hydroxytryptamine 7 agonist | 0.053 0.045 DBMET01480 0.053 0.045 DBMET01481 | DBMET01481 | |
| 0.025 | 0.106 | 0.086 | Carbonic anhydrase inhibitor | 0.086 0.032 DBMET01481 | DBMET01481 | |
| 0.063 | 0.145 | 0.142 | Nitric-oxide synthase inhibitor | 0.094 0.07 DBMET01480 0.142 0.026 DBMET01481 | DBMET01481 | |
| 0.047 | 0.132 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.045 DBMET01481 | DBMET01481 | |
| 0.141 | 0.227 | 0.185 | Transcription factor STAT3 inhibitor | 0.185 0.156 DBMET01480 0.185 0.156 DBMET01481 | DBMET01481 | |
| 0.04 | 0.127 | 0.06 | Aryl hydrocarbon receptor antagonist | 0.06 0.054 DBMET01480 0.06 0.054 DBMET01481 | DBMET01481 | |
| 0.026 | 0.113 | 0.045 | CC chemokine 4 receptor antagonist | 0.045 0.037 DBMET01480 0.045 0.037 DBMET01481 | DBMET01481 | |
| 0.126 | 0.215 | 0.174 | DNA damaging | 0.174 0.141 DBMET01480 0.174 0.141 DBMET01481 | DBMET01481 | |
| 0.013 | 0.103 | 0.069 | Carbonic anhydrase IX inhibitor | 0.069 0.033 DBMET01481 | DBMET01481 | |
| 0.013 | 0.105 | 0.062 | Carbonic anhydrase XII inhibitor | 0.062 0.032 DBMET01481 | DBMET01481 | |
| 0.031 | 0.124 | 0.058 | Cyclin D1 inhibitor | 0.058 0.047 DBMET01480 0.058 0.047 DBMET01481 | DBMET01481 | |
| 0.051 | 0.145 | 0.122 | Inducible nitric-oxide synthase inhibitor | 0.078 0.066 DBMET01480 0.122 0.024 DBMET01481 | DBMET01481 | |
| 0.025 | 0.123 | 0.076 | Beta 1 adrenoreceptor antagonist | 0.076 0.021 DBMET01481 | DBMET01481 | |
| 0.062 | 0.161 | 0.095 | Proteasome inhibitor | 0.095 0.094 DBMET01480 0.095 0.094 DBMET01481 | DBMET01481 | |
| 0.072 | 0.171 | 0.107 | Alkaline phosphatase inhibitor | 0.107 0.105 DBMET01480 0.107 0.105 DBMET01481 | DBMET01481 | |
| 0.032 | 0.131 | 0.051 | Fatty acid synthase inhibitor | 0.051 0.05 DBMET01480 0.051 0.05 DBMET01481 | DBMET01481 | |
| 0.076 | 0.178 | 0.112 | Interleukin 8 antagonist | 0.112 0.073 DBMET01480 0.112 0.073 DBMET01481 | DBMET01481 | |
| 0.041 | 0.144 | 0.086 | Androgen antagonist | 0.086 0.059 DBMET01481 | DBMET01481 | |
| 0.09 | 0.194 | 0.133 | Thiol protease inhibitor | 0.133 0.09 DBMET01480 0.133 0.09 DBMET01481 | DBMET01481 | |
| 0.034 | 0.14 | 0.083 | Beta adrenoreceptor antagonist | 0.083 0.025 DBMET01481 | DBMET01481 | |
| 0.083 | 0.19 | 0.13 | Phospholipase A2 inhibitor | 0.13 0.1 DBMET01481 | DBMET01481 | |
| 0.028 | 0.136 | 0.108 | Alpha 2 adrenoreceptor agonist | 0.108 0.012 DBMET01481 | DBMET01481 | |
| 0.066 | 0.176 | 0.09 | Phosphodiesterase 6D inhibitor | 0.09 0.075 DBMET01480 0.09 0.075 DBMET01481 | DBMET01481 | |
| 0.061 | 0.172 | 0.095 | Protein kinase C gamma inhibitor | 0.095 0.086 DBMET01480 0.095 0.086 DBMET01481 | DBMET01481 | |
| 0.097 | 0.209 | 0.224 | Insulin sensitizer | 0.162 0.117 DBMET01480 0.224 0.052 DBMET01481 | DBMET01481 | |
| 0.049 | 0.165 | 0.079 | Histamine H2 receptor antagonist | 0.079 0.068 DBMET01480 0.079 0.068 DBMET01481 | DBMET01481 | |
| 0.014 | 0.13 | 0.034 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.034 0.024 DBMET01481 | DBMET01481 | |
| 0.08 | 0.207 | 0.138 | Pyruvate kinase inhibitor | 0.138 0.127 DBMET01480 0.138 0.127 DBMET01481 | DBMET01481 | |
| 0.094 | 0.222 | 0.179 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.179 0.114 DBMET01480 0.179 0.114 DBMET01481 | DBMET01481 | |
| 0.086 | 0.215 | 0.127 | Neuropeptide Y1 antagonist | 0.127 0.107 DBMET01480 0.127 0.107 DBMET01481 | DBMET01481 | |
| 0.058 | 0.196 | 0.12 | Caspase 3 inhibitor | 0.102 0.089 DBMET01480 0.12 0.059 DBMET01481 | DBMET01481 | |
| 0.04 | 0.178 | 0.089 | Adenosine A3 receptor antagonist | 0.089 0.033 DBMET01481 | DBMET01481 | |
| 0.106 | 0.248 | 0.192 | Calpain inhibitor | 0.192 0.121 DBMET01480 0.192 0.121 DBMET01481 | DBMET01481 | |
| 0.073 | 0.217 | 0.174 | Aryl hydrocarbon receptor agonist | 0.174 0.118 DBMET01480 0.174 0.118 DBMET01481 | DBMET01481 | |
| 0.046 | 0.191 | 0.078 | Caspase 7 inhibitor | 0.078 0.065 DBMET01480 0.078 0.065 DBMET01481 | DBMET01481 | |
| 0.041 | 0.191 | 0.15 | Potassium channel activator | 0.15 0.02 DBMET01481 | DBMET01481 | |
| 0.033 | 0.187 | 0.088 | NMDA receptor antagonist | 0.088 0.056 DBMET01481 | DBMET01481 | |
| 0.031 | 0.191 | 0.074 | Potassium channel (ATP-sensitive) blocker | 0.074 0.035 DBMET01481 | DBMET01481 | |
| 0.05 | 0.218 | 0.132 | Nav1.6 sodium channel blocker | 0.132 0.078 DBMET01480 0.132 0.078 DBMET01481 | DBMET01481 | |
| 0.033 | 0.202 | 0.104 | Calcium channel L-type blocker | 0.104 0.023 DBMET01481 | DBMET01481 | |
| 0.014 | 0.187 | 0.052 | Adenosine A1 receptor antagonist | 0.052 0.047 DBMET01481 | DBMET01481 | |
| 0.017 | 0.196 | 0.051 | Potassium channel (Inward rectifier) blocker | 0.051 0.033 DBMET01481 | DBMET01481 | |
| 0.109 | 0.287 | 0.268 | Transcription factor NF kappa B inhibitor | 0.268 0.114 DBMET01481 | DBMET01481 | |
| 0.108 | 0.295 | 0.232 | Calpain 2 inhibitor | 0.232 0.162 DBMET01480 0.232 0.162 DBMET01481 | DBMET01481 | |
| 0.048 | 0.246 | 0.107 | Toll-Like receptor 9 antagonist | 0.107 0.101 DBMET01480 0.107 0.101 DBMET01481 | DBMET01481 | |
| 0.028 | 0.24 | 0.076 | Acetylcholine agonist | 0.076 0.072 DBMET01481 | DBMET01481 | |
| 0.072 | 0.288 | 0.153 | Hemostatic | 0.153 0.065 DBMET01481 | DBMET01481 | |
| 0.019 | 0.236 | 0.094 | Alpha adrenoreceptor agonist | 0.094 0.03 DBMET01481 | DBMET01481 | |
| 0.028 | 0.254 | 0.088 | Adrenaline agonist | 0.088 0.048 DBMET01481 | DBMET01481 | |
| 0.046 | 0.309 | 0.126 | Cytokine production inhibitor | 0.126 0.084 DBMET01481 | DBMET01481 | |
| 0.049 | 0.412 | 0.135 | Antipruritic | 0.135 0.114 DBMET01481 | DBMET01481 | |
| 0.032 | 0.412 | 0.14 | Calcium channel blocker | 0.14 0.068 DBMET01481 | DBMET01481 | |
| 0.031 | 0.413 | 0.102 | Calcium channel (voltage-sensitive) blocker | 0.102 0.081 DBMET01481 | DBMET01481 | |
| 0.041 | 0.424 | 0.157 | Antiamyloidogenic | 0.157 0.139 DBMET01481 | DBMET01481 | |
| 0.019 | 0.596 | 0.925 | Platelet antagonist | 0.925 0.003 DBMET01481 | DBMET01481 | |
| 0.005 | 0.602 | 0.128 | Phosphodiesterase 4C inhibitor | 0.128 0.01 DBMET01481 | DBMET01481 | |
| 0.007 | 0.932 | 0.767 | Angiogenesis stimulant | 0.767 0.004 DBMET01481 | DBMET01481 | |
| 0.003 | 0.961 | 0.39 | Aldose reductase inhibitor | 0.39 0.004 DBMET01481 | DBMET01481 | |
| 0.004 | 0.967 | 0.854 | Free radical scavenger | 0.854 0.004 DBMET01481 | DBMET01481 | |
| 0.004 | 0.967 | 0.366 | Lipid peroxidase inhibitor | 0.366 0.012 DBMET01481 | DBMET01481 | |
| 0.003 | 0.99 | 0.953 | Cyclooxygenase 1 inhibitor | 0.953 0.002 DBMET01481 | DBMET01481 | |
| 0.004 | 0.991 | 0.788 | Platelet aggregation inhibitor | 0.788 0.004 DBMET01481 | DBMET01481 | |
| 0.005 | 0.995 | 0.212 | Caspase 9 inhibitor | 0.212 0.004 DBMET01481 | DBMET01481 | |
| 0.003 | 0.994 | 0.961 | Cyclooxygenase inhibitor | 0.961 0.002 DBMET01481 | DBMET01481 | |
| 0.004 | 0.995 | 0.661 | Antioxidant | 0.661 0.008 DBMET01481 | DBMET01481 | |
| 0.003 | 0.995 | 0.953 | Cyclooxygenase 2 inhibitor | 0.953 0.002 DBMET01481 | DBMET01481 | |
| 0.003 | 0.996 | 0.323 | Hepatoprotectant | 0.323 0.024 DBMET01481 | DBMET01481 | |
| 0.003 | 0.996 | 0.622 | Apoptosis agonist | 0.622 0.044 DBMET01481 | DBMET01481 | |
| 0.002 | 0.996 | 0.188 | Maillard reaction inhibitor | 0.188 0.004 DBMET01481 | DBMET01481 | |
| 0.002 | 0.997 | 0.24 | Bone formation stimulant | 0.24 0.027 DBMET01481 | DBMET01481 | |
| 0.003 | 0.997 | 0.32 | Apoptosis antagonist | 0.32 0.073 DBMET01481 | DBMET01481 | |
| 0.002 | 0.997 | 0.379 | Acetylcholinesterase inhibitor | 0.379 0.008 DBMET01481 | DBMET01481 | |
| 0.001 | 0.997 | 0.669 | Guanylate cyclase stimulant | 0.669 0.001 DBMET01481 | DBMET01481 | |
| 0.001 | 0.996 | 0.33 | Guanylate cyclase 1 stimulant | 0.33 0.002 DBMET01481 | DBMET01481 | |
| 0.002 | 0.997 | 0.816 | Cardiotonic | 0.816 0.004 DBMET01481 | DBMET01481 | |
| 0.002 | 0.998 | 0.687 | Hypoglycemic | 0.687 0.005 DBMET01481 | DBMET01481 | |
| 0.002 | 0.997 | 0.236 | Cholinergic | 0.236 0.033 DBMET01481 | DBMET01481 | |
| 0.002 | 0.998 | 0.496 | Insulin secretagoues | 0.496 0.005 DBMET01481 | DBMET01481 | |
| 0.001 | 0.997 | 0.02 | Angiotensin AT2 receptor antagonist | 0.02 0.015 DBMET01481 | DBMET01481 | |
| 0.001 | 0.998 | 0.812 | Platelet adhesion inhibitor | 0.812 0.002 DBMET01481 | DBMET01481 | |
| 0.001 | 0.998 | 0.67 | Butyrylcholinesterase inhibitor | 0.67 0.003 DBMET01481 | DBMET01481 | |
| 0 | 0.999 | 0.052 | H+/K+-transporting ATPase inhibitor | 0.052 0.034 DBMET01481 | DBMET01481 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |